학술논문
A Phase 1–2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC
Document Type
Article
Author
Malhotra, Jyoti; Nikolinakos, Petros; Leal, Ticiana; Lehman, Jonathan; Morgensztern, Daniel; Patel, Jyoti D.; Wrangle, John M.; Curigliano, Giuseppe; Greillier, Laurent; Johnson, Melissa L.; Ready, Neal; Robinet, Gilles; Lally, Satwant; Maag, David; Valenzuela, Ricardo; Blot, Vincent; Besse, Benjamin
Source
In Journal of Thoracic Oncology September 2021 16(9):1559-1569
Subject
Language
ISSN
1556-0864